Source: © taraki - Fotolia.com

Cancer Centers, Illumina Form Group to Set Cancer NGS Standards

Four cancer research institutes have joined with Illumina to form a consortium that will recommend standards for applying next-generation sequencing to cancer tumors. The new...
Source: © SSilver/Fotolia.com

Whole-Exome Sequencing Technology Identifies Drug Resistance Gene in Testicular Cancer

A study, funded by the Movember Foundation and conducted by scientists at The Institute of Cancer Research (ICR) in London, has revealed several genetic...
Seegene will partner its Allplex™ assays with Thermo Fisher Scientific’s PCR System (Source: Seegene)

Seegene Partners with Thermo Fisher Scientific to Enter U.S. Diagnostics Market

Seegene said it will partner Allplex™ assay with Thermo Fisher Scientific’s PCR System, aiming to create a comprehensive MDx solution
Source: Bainscou / Wickimedia Commons

Diagnostics Leveraging Next-Generation Sequencing Become Mainstream for Cancer and Rare Diseases

Diagnostics Leveraging Next-Generation Sequencing Become Mainstream for Cancer and Rare Diseases
Source:  ktsimage/Getty Images

Secondary Findings in Genomic Sequencing Get New Reporting Recommendations

ACMG releases new recommendations for reporting of secondary findings in clinical exome and genome sequencing.
Meeting handshake

Veracyte Nabs Exclusive Global License for Diagnostic Use of Nanostring’s nCounter Technology

The company will initially use the FDA-cleared, automated nCounter system which can simultaneously analyze RNA, DNA or protein targets in up to 800 genes, for uses in diopathic pulmonary fibrosis diagnosis and breast cancer diagnosis.
Quartz-made Nanopillars of 250-nm diameter were arrayed inside nanoslit region of 100-nm high and applied for ultrafast microRNA extraction from nucleic acids mixture. [Noritada Kaji]

Nanobiodevice Could Become Rapid Cancer Molecular Diagnostic

Scientific collaboration yields a pioneering nanobiodevice that can isolate cancer biomarkers quickly with high resolution.
Clinical OMICs Magazine: Volume 5

Medically, Proteomics Advances Will Rival the Genetics Advances of the Last Ten Years

Seventy percent of the decisions made by physicians today are influenced by results of diagnostic tests, according to N. Leigh Anderson, founder of the...
Cloudian Hyperstore

Triple Threat: OnRamp Bioinformatics, Cloudian, ScaleMatrix Combine Services for Genomic Data Analysis and...

OnRamp Bioinformatics, Cloudian, ScaleMatrix Combine Services for Genomic Data Analysis and Storage Offering
Source: STEVE GSCHMEISSNER/SPL/Getty Images

Newly Developed Compound Targets Epigenetic Changes in Melanoma Cells

The novel compound, dubbed corin, targets specific epigenetic-modifying proteins to successfully inhibit the growth of melanoma cells
Scroll Up